XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity Based Compensation (Narrative) (Details) - USD ($)
$ / shares in Units, $ in Millions
6 Months Ended 9 Months Ended
Jun. 30, 2022
Sep. 30, 2022
Sep. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Equity compensation expense   $ 31 $ 40
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value 258,327    
Stock appreciation rights granted, weighted average exercise price (per share)   $ 106.53  
Shares Granted To Non Employee Directors   17,937  
Document Period End Date   Sep. 30, 2022  
Options exercisable (shares)   1,652,736  
Options exercisable, weighted average price (per share)   $ 107.03  
Options, remaining term   4 years 2 months 12 days  
Compensation cost not yet recognized   $ 31  
Period for recognition   8 months 12 days  
Performance Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value   78,687  
Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value   219,553